Consensus Insulet Corporation

Equities

PODD

US45784P1012

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
166.2 ^USD	+0.92%		-5.12%	-23.38%

Mar. 20	US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	MT
Mar. 20	Insulet Names Ana Maria Chadwick Finance Chief	MT

Evolution of the average Target Price on Insulet Corporation

Price target over the last 5 years

History of analyst recommendation changes

48c2eea3d47564c0db30cedb72ccf2._U0OEFkZHtTXFc0-HjjOW7fZerhGlccqHR4pvEuIUVQ.hyxGaS8uSpefe5QKLnL8PMG7SNU___RtR2pPiz_CIjqxeE8nKGpIrr1zgA~4c3510d51a2e9fbd20798bc15072fcce

Analyst Recommendations on Insulet Corporation

Barclays Trims Insulet Price Target to $213 From $214, Maintains Equal Weight Rating	Feb. 26	MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking...	Feb. 05
UBS Raises Insulet Price Target to $211 From $175, Maintains Neutral Rating	Jan. 22	MT
Baird Upgrades Insulet to Outperform From Neutral, Raises Price Target to $238 From $180	Dec. 21	MT
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments...	Dec. 21
Morgan Stanley Upgrades Insulet to Overweight From Equalweight, Raises Price Target to $234 From $185	Dec. 04	MT
ANALYST RECOMMENDATIONS : Adobe, Broadcom, Comcast, Fair Isaac, Salesforce...	Dec. 04
ANALYST RECOMMENDATIONS : Boeing, Datadog, Estee Lauder, Qualcomm, Snowflake...	Nov. 28
ANALYST RECOMMENDATIONS : Apple, ADP, Fortinet, General Motors, S&P...	Nov. 03
BofA Slashes Price Target on Insulet to $180 From $295, Keeps Buy Rating	23-10-18	MT
Out with the old	23-10-02
Jefferies Upgrades Insulet to Buy From Hold	23-10-02	MT
ANALYST RECOMMENDATIONS : Amgen, Best Buy, Comcast, Fedex, Mosaic...	23-10-02
Morgan Stanley Adjusts Price Target on Insulet to $185 From $208, Maintains Equal-Weight Rating	23-09-29	MT
Raymond James Cuts Insulet Price Target to $228 From $299, Maintains Outperform Rating	23-09-15	MT
UBS Adjusts Insulet Price Target to $215 From $270, Maintains Neutral Rating	23-09-06	MT
BofA Securities Adjusts Insulet's Price Target to $295 From $365, Keeps Buy Rating	23-08-24	MT
Morgan Stanley Adjusts Price Target on Insulet to $208 From $343, Maintains Equalweight Rating	23-08-24	MT
Citigroup Upgrades Insulet to Buy From Neutral, Adjusts Price Target to $265 From $273	23-08-21	MT
Baird Downgrades Insulet to Neutral From Outperform, Adjusts Price Target to $219 From $320	23-08-21	MT
Barclays Adjusts Price Target on Insulet to $257 From $329, Maintains Equalweight Rating	23-08-10	MT
Raymond James Adjusts Price Target on Insulet to $299 From $350, Keeps Outperform Rating	23-08-09	MT
Citigroup Lowers Price Target on Insulet to $319 From $330, Maintains Neutral Rating	23-07-11	MT
Barclays Adjusts Price Target on Insulet to $329 From $292, Maintains Equalweight Rating	23-05-08	MT
Baird Adjusts Insulet's Price Target to $370 From $350, Keeps Outperform Rating	23-05-05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

166.2 USD

Average target price

236.3 USD

Spread / Average Target

+42.11%

High Price Target

270 USD

Spread / Highest target

+62.41%

Low Price Target

208 USD

Spread / Lowest Target

+25.11%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Insulet Corporation

Barclays
UBS
Baird
Morgan Stanley
BofA Securities
Jefferies & Co.
Raymond James
Citigroup
Piper Sandler
Stifel Nicolaus
BTIG
Baptista Research
Wolfe Research
Canaccord Genuity
JPMorgan Chase
SVB Leerink
Oppenheimer
Berenberg Bank
Cowen

Ratings for Insulet Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar